ReviewThe Journal of international medical research2026
Development and application of organoid technology in pituitary neuroendocrine tumor research.
Review in The Journal of international medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This review examines the development of organoid technology and its recent advances in the study of pituitary neuroendocrine tumors. As three-dimensional in vitro culture models, organoids can recapitulate the structural and functional characteristics of native organs, providing an innovative platform for investigating disease mechanisms, conducting drug screening, and developing personalized treatment strategies for pituitary neuroendocrine tumors. The article begins with an overview of the historical progression of organoid technology and then focuses on its specific applications in pituitary neuroendocrine tumor research, including disease modeling, drug testing, and potential uses in regenerative medicine. Finally, it addresses current challenges in the field and outlines future research directions and potential clinical applications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.